HGF and cholangiocarcinoma: Through downregulating miR-320a, TTA-AS1 promotes cell cycle progression, EMT, and angiogenesis via NRP-1, which co-interacts HGF/c-Met and TGF-β/TGF-βRI pathways in CCA cells.